Biotech deep tech funds invest at the intersection of biology and technology, backing companies that leverage AI-driven drug discovery, novel therapeutic modalities, and advanced diagnostics to fundamentally improve human health outcomes.
118 funds
Geneva, Switzerland
Boston, United States
London, United Kingdom
Seattle, United States
San Francisco, United States
Waltham, United States
Pasadena, United States
New York, United States
Stockholm, Sweden
Berlin, Germany
New York, United States
Chicago, United States
San Francisco, United States
Cambridge, United Kingdom
Cambridge, United States
La Jolla, United States
Boston, United States
London, United Kingdom
St. Louis, United States